| 000 | 01519 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250517050850.0 | ||
| 264 | 0 | _c20160630 | |
| 008 | 201606s 0 0 eng d | ||
| 022 | _a1744-8409 | ||
| 024 | 7 |
_a10.1586/1744666X.2015.1077702 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKoné-Paut, Isabelle | |
| 245 | 0 | 0 |
_aCurrent treatment recommendations and considerations for cryopyrin-associated periodic syndrome. _h[electronic resource] |
| 260 |
_bExpert review of clinical immunology _c2015 |
||
| 300 |
_a1083-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aCarrier Proteins _xgenetics |
| 650 | 0 | 4 |
_aCryopyrin-Associated Periodic Syndromes _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunity, Innate _xgenetics |
| 650 | 0 | 4 |
_aInterleukin 1 Receptor Antagonist Protein _xtherapeutic use |
| 650 | 0 | 4 |
_aInterleukin-1beta _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMutation _xgenetics |
| 650 | 0 | 4 | _aNLR Family, Pyrin Domain-Containing 3 Protein |
| 650 | 0 | 4 |
_aReceptors, Interleukin-1 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aGaleotti, Caroline | |
| 773 | 0 |
_tExpert review of clinical immunology _gvol. 11 _gno. 10 _gp. 1083-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1586/1744666X.2015.1077702 _zAvailable from publisher's website |
| 999 |
_c25206990 _d25206990 |
||